Topics discussed in this post:
- BACKGROUND EFFORTS OF THIS PROGRAM
- WHO IS MENSSANA, AND HOW CAN THEY HELP US?
- WHICH PROGRAM WAS SELECTED BY MEBO?
- WHAT IS INVOLVED IN THE TEST/STUDY PROCESS?
- WHAT WILL BE DONE WITH THE TEST RESULTS?
- HOW WILL THIS BENEFIT THE SUFFERER WHO PAID FOR HIS/HER TEST?
- HOW IS THIS TEST DIFFERENT FROM THOSE WHO TEST FOR ORAL HALITOSIS?
MEBO/Menssana Alveolar Breath Test Study |
First of all,I would like to thank Mike, MEBO’s Managing Director and my right hand person in MEBO’s administration, for having taken the initiative
to contact Dr. Michael Phillips, MD, PACP, to initiate this testing process. Mike has written a very good post introducing the program he and Dr. Phillips designed for our community, New alveolar breath test for chemicals study! This post has stirred up our international community with a sense of newly found hope, and your emails have been pouring in to Mike, much to our delight. In an effort to help Mike handle this large volume of emails, I would like to write this post to answer some of your questions.
BACKGROUND EFFORTS OF THIS PROGRAM
MEBO Research first approached Dr. Phillips in January 2009, five (5) months before MEBO registered as a company in England, since we were impressed with his work and credentials. Dr. Phillips was very moved with desire to help our community, but we were so scattered and not organized under one flagship, and the efforts soon fell apart. In fact, it was this very depressing experience that drove me to create MEBO Research registered in the UK and the US, and eventually upgraded to a Charity. Then, Mike joined MEBO now in 2011, and without knowing of our efforts back in 2009, initiated this effort again. He too sensed that we need to “think out of the box” and to think beyond TMAU to research the cause of odor not only of persons who do not suffer with TMAU, but also of those who do suffer with TMAU. This time, Dr. Phillips was impressed at just how far our community has grown and organized in less than three years (3), and was moved to work with Mike to offer us a series of testing/research programs that we could select from, and I’m very happy to say that this is where we are today.
WHO IS MENSSANA, AND HOW CAN THEY HELP US?
As we published in a post in this blog back in January 2009, Dr Michael Phillips Breath test talk at Pittcon 2009 Chicago, March 10, Menssana’s equipment has been used to perform breath tests sensitive enough to evaluate and predict the following conditions before symptoms are fully manifested,
- lung cancer *
- breast cancer *
- heart transplant rejection *
- kidney disease
- ischemic heart disease
- diabetes mellitus
- development of the next-generation BCA *
With such an impressive level of sensitivity, MEBO became very interested and enthusiastic in pursuing this type of testing for our community. Dr. Phillips assures us that this test is sensitive enough to detect some metabolic deficiencies through the detection of alveolar chemicals, which may include volatile organic compounds (VOCs), or odorous chemicals, that flow in our blood and comes out in our breath, as well as other “cleansing organs” of our body.
WHICH PROGRAM WAS SELECTED BY MEBO RESEARCH, INC.
Based on MEBO’s financial limitations, and with a clear understanding and consideration of the financial limitations of sufferers in the current day global economy, we have selected a program that will be supported with a small grant and sufferer-funded (by persons testing). The small grant will cover the program set-up fee, which includes the cost of a control group of 20 subjects, and each sufferer wishing to test will be charged as low a rate as possible, thanks to the help of MEBO volunteers who offer their time and efforts without compensation.
The primary focus of the test/study selected is not only to test for systemic halitosis, also known as alveolar halitosis, or bloodborne halitosis, but primarily to identify metabolic malfunctions. By determining the specific chemicals detected in each person’s alveolar breath, and by comparing them to the control group, Dr. Phillip will be able to identify in his study which VOCs are more elevated in sufferers of body odor conditions.
WHAT WILL BE DONE WITH THE TEST RESULTS?
Once identified, the study will involve tracing the source of these VOCs. This stage might also involve other experts in the United States and United Kingdom, who have already offered to assist MEBO in whichever way they can, in addition to Dr. Phillips and his staff. These are the initial questions to be addressed in follow-up studies once data has been collected from the VOCs.
- Are the VOCs produced by microorganisms in our gut, and if so, which ones?
- Are the VOCs detected in elevated levels the end product of a faulty metabolic system, and if so, which enzymes are involved?
- Is there a genetic cause for these elevated levels of particular VOCs?
- What treatment protocol would apply to each type of VOC and its cause, as determined by the appropriate test(s)?
HOW WILL THIS BENEFIT THE SUFFERER WHO PAID FOR HIS/HER TEST?
HOW IS THIS TEST DIFFERENT FROM THOSE WHO TEST FOR ORAL HALITOSIS? Oral halitosis testing may involve detection of VOCs produced in the oral cavity, including the dorsal tongue. These tests are available at breath clinics by well renowned dentists and other professionals. The alveolar test performed by Dr. Phillips is much more sensitive, and tests the breath that comes from the lungs that includes chemicals filtered through the lungs and excreted in the breath. In theory, there is a possibility that if the alveolar breath containing chemicals that have a much higher pH, such as trimethylamine (TMA), it could create an altered pH in the mouth contributing to microbial imbalance, and thus conducive to the creation of volatile organic compounds, (odorous chemicals) produced by overpopulated microorganisms. In effect, testing for both, alveolar and oral halitosis would be beneficial because both might need to be treated to control this chronic and persistent condition. However, due to financial limitations, we may only initially perform the alveolar breath test, but this is subject to change. I hope this clarifies some of your concerns, and helps answer some of your questions.
María de la Torre
Founder and Executive Director
A Public Charity
www.meboresearch.org
www.brasil.meboresearch.org
maria.delatorre@meboresearch.org
MEBO's Blog (English)
El Blog de MEBO (español)
MEBO Brasil - Blog (Portuguese)
0 comments: